Bayer Animal Health Taps into Paraco's Molecules

Bayer Animal Health and Paraco Technology (Palmerston North, New Zealand), a start up biotech company, owned by New Zealand's AgResearch, have signed an option agreement allowing Bayer exclusive access to Paraco's current lead molecules for testing and development in animal health. The focus is on research into parasiticides. Paraco, although supported financially by AgResearch, is keen to raise external funds to allow it to progress its lead molecules quickly, says Ian Boddy, managing director of Paraco. Bayer Animal Health, a part of Bayer HealthCare, had sales...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers